Biodesix (BDSX) Equity Ratio (2019 - 2026)

Biodesix (BDSX) has reported Equity Ratio for 8 consecutive years, with 0.1 the latest figure, recorded in Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.1, down 24.76% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.1 (down 24.76% YoY), and the FY2025 annual result was 0.03, down 113.13% from the prior year.
• Equity Ratio was 0.1 for Q1 2026 at Biodesix, up from 0.03 in the prior quarter.
• Over five years, Equity Ratio peaked at 0.31 in Q2 2024 and troughed at 0.09 in Q2 2023.
• Average Equity Ratio over 5 years is 0.08, with a median of 0.06 recorded in 2023.
• The widest YoY moves for Equity Ratio: up 1727.28% in 2024, down 212.04% in 2024.
• Over 5 years, Equity Ratio stood at 0.22 in 2022, then tumbled by 79.16% to 0.05 in 2023, then surged by 364.49% to 0.21 in 2024, then slumped by 113.13% to 0.03 in 2025, then surged by 442.43% to 0.1 in 2026.
• Per Business Quant data, the three most recent Equity Ratio figures were 0.1 in Q1 2026, 0.03 in Q4 2025, and 0.02 in Q3 2025.